Recombinant Vaccines Market By Product (Attenuated, Vector, and Subunit), By Application (Veterinary and Human), By Disease (Hepatitis B, Cancer, Influenza, and Others), and By Distribution Channel (Hospitals, Clinics, Veterinary Clinics, Retail Pharmacies, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Global recombinant vaccines market expected to generate around USD 1,685 million by 2025, at a CAGR of around 6.5% between 2019 and 2025. Recombinant DNA molecules are prepared by genetic recombination methods to link genetic material from various sources.

11-Oct-2019 | Number of pages: 110 | Report Code: ZMR-4836 | Report Format : | Status : Published

Analysis

A vaccine is a biological product that offers active attained immunity against a specific disease. A recombinant vaccine is manufactured via recombinant DNA (rDNA) technology. This includes introducing the DNA (Deoxyribonucleic Acid) encoding an antigen, which encourages an immune reaction into mammalian or bacterial cells, by articulating the antigen in these cells and then refining it from them.

The safe to use nature of recombinant vaccines, high investments by recombinant vaccine manufacturers for novel products’ development, rising government initiatives to boost the recombinant vaccines usage, increasing augmented and viable healthcare demand, simplified applications of recombinant vaccines, and growing accessibility of recombinant vaccines via conventional supply chains, escalating number of regulatory authorizations, and growing infectious diseases occurrence are driving the recombinant vaccines market globally. The rising awareness regarding recombinant vaccines benefits in developing regions, increasing per capita healthcare expenditure, growing demand for veterinary recombinant vaccines, and ongoing technological improvements in recombinant vaccines will create additional opportunities for the recombinant vaccines market in the years ahead. However, risks related to the use of attenuated vaccines, high cost of recombinant vaccines, and the lack of appropriate healthcare setup and trained physicians in developing regions will restrict the global recombinant vaccines market development.

Global Recombinant Vaccines Market

The recombinant vaccines market is split based on type, application, disease, and distribution channel. Based on type, the recombinant vaccines market includes attenuated, vector, and subunit. The subunit segment accounted for the highest market share in 2018. The application segment includes veterinary and human. The human segment accounted for the highest market share in 2018. The disease segment comprises hepatitis B, cancer, influenza, and others. The hepatitis B segment is expected to register the highest CAGR over the estimated time period. The distribution channel segment is fragmented into hospitals, clinics, veterinary clinics, retail pharmacies, and others.

North America will lead the global recombinant vaccines market in the future, owing to rising developments in the field of genetic engineering and molecular biology, increasing transmittable diseases prevalence, huge research and development expenditure by major manufacturers, high vaccination rate, and rapid uptake of techniques like rDNA technology. Europe will hold the second spot in this global market, due to the presence of latest treatment facilities, high healthcare expenditure, rising infectious disorders incidences, escalating cancer rate, and growing availability of latest healthcare infrastructure. The Asia Pacific will grow rapidly over the forecast period, owing to the rising government initiatives governments to increase vaccination rate, an enormous patient pool, increasing investments by domestic and global manufacturers, escalating need for large quantities of vaccines, and ongoing R&D.

Some key players of the global recombinant vaccines market are Pfizer, Merck, Sanofi Pasteur, Bayer, GlaxoSmithKline, Serum Institute of India, Abiomed, Johnson & Johnson, Emergent Bio Solutions, and Mitsubishi Tanabe Pharma.


Related Reports

Hydroxychloroquine Market - By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade, and Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus, and Others), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Apr-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5346 | Report Format:

The global Hydroxychloroquine market value was estimated at 542 (USD Million) in 2019 and is projected to hit 5,000 (USD Million) by 2025 growing at a CAGR of over 33% during the period from 2019 to 2025. The report offers valuation and analysis of the Hydroxychloroquine market on a global as well...Read More

Hyperhidrosis Treatment Market: By Treatment Type (Botulinum Toxin A, Non-Surgical Microwave Energy Destruction of Sweat Glands, Iontophoresis, Topical Treatments, Surgical Treatments, and Others), By Type (Axillary Hyperhidrosis, Plantar Hyperhidrosis, Palmar Hyperhidrosis, and Others), and By End-User (Hospitals, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Jan-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5214 | Report Format:

The report includes Revenue forecast analysis of the hyperhidrosis treatment market on a global as well as regional level. It also offers historic data of 2016 and 2017 and provides a valuation of the industry surge during 2019-2025 in terms of USD Billion. Our study includes competitive strategi...Read More

Home Blood Pressure Monitoring Devices Market: by Product (Upper Arm Monitors, Wrist Monitors, and Accessories), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5131 | Report Format:

According to the report, global demand for home blood pressure monitoring devices market was valued at USD 1,093.1 million in 2018, and is expected to generate revenue of USD 1,611.3 million by end of 2025, growing at a CAGR of 5.7% between 2019 and 2025 The report covers forecast and analysis f...Read More

Orthostatic Hypotension Drugs Market: by Diagnostic Test Type (ECG, Blood Tests, Stress Test and Other), Drug Type (Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others) and End user (Hospitals, ASCs and Clinics and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5123 | Report Format:

The report covers forecast and analysis for the Orthostatic Hypotension Drugs market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Orthosta...Read More

Carcinoembryonic Antigen Market: by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications); by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5122 | Report Format:

The report covers forecast and analysis for the carcinoembryonic antigen market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the carcinoembryonic antige...Read More

Request Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.